Transdermal delivery of loratadine
US4910205A · kind A · utility
22Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 1988 |
| Grant date | Mar 20, 1990 |
| Priority date | — |
| Expiry date | May 2, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for the transdermal delivery of loratadine comprising isopropyl myristate and rosemary oil and the method of using such a composition for the treatment of allergic reactions are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.